BBIO
BridgeBio Pharma Inc
66.60$
-1.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 6.2% | 37.4% | 4.5% | 4.4% | 26.3% | 1.7% | 5.6% | |
| – | – | 93.8% | 100.0% | 95.5% | 95.6% | 73.7% | 98.3% | 94.4% | |
| – | – | 517.6% | 4,085.9% | 646.9% | 514.5% | 4,898.5% | 228.2% | 95.1% | |
| – | – | 232.6% | 1,766.1% | 275.7% | 184.4% | 1,618.7% | 113.1% | 105.8% | |
| – | – | 750.2% | 5,852.0% | 922.6% | 755.2% | 6,602.5% | 365.5% | 207.7% | |
| – | – | -656.4% | -5,752.0% | -827.1% | -659.6% | -6,528.8% | -267.2% | -113.3% | |
| – | – | 21.6% | 444.4% | 67.1% | 103.6% | 873.8% | 44.7% | 10.6% | |
| – | – | -711.5% | -6,127.9% | -841.2% | -624.2% | -7,021.9% | -244.3% | -146.4% | |
| – | – | -69.4% | -261.4% | 75.8% | 12.0% | 768.7% | 0.5% | 0.1% | |
| – | – | -642.1% | -5,439.7% | -806.9% | -619.7% | -6,913.9% | -241.4% | -145.3% | |
| – | – | -687.8% | -5,665.9% | -765.7% | -511.9% | -6,078.3% | -196.9% | -134.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.